glp-1 hypothalamus From metabolism to mind: The expanding role of the receptor in neurotherapeutics Schematic representation of GLP-1/GLP-1R axis
Description
This explains the clinical pivot toward injectable and oral options that deliver predictable GLP-1 concentrations
Abdominal pain A total of 12 trials were evaluated regarding the risk of abdominal pain in patients receiving GLP-1 RAs
Are there any long-term side effects of Mounjaro
THE IMPLICATION IS CLEAR: MANUFACTURING CAPACITY IS BECOMING A STRATEGIC ASSET RATHER THAN AN OPERATIONAL AFTERTHOUGHT. This means that, even with significant investment, expansion will lag behind growing demand
In all likelihood, clinicians will probably continue to use the big two (semaglutide and tirzepatide) for people who can access and afford them
